688131 皓元醫藥
按盤價 
44.100 +5.840 (+15.264%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.142 | 7.484 | 5.278 | 9.350 | 16.253 |
| 總資產報酬率 ROA (%) | 1.112 | 4.158 | 3.272 | 6.474 | 11.784 |
| 投入資產回報率 ROIC (%) | 1.244 | 4.708 | 3.785 | 7.555 | 13.863 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.583 | 47.965 | 45.168 | 51.444 | 54.118 |
| 營業利潤率 (%) | 12.356 | 10.432 | 6.826 | 14.474 | 21.641 |
| 息稅前利潤/營業總收入 (%) | 13.540 | 12.020 | 8.513 | 14.577 | 22.261 |
| 淨利潤/營業總收入 (%) | 10.093 | 8.719 | 6.718 | 14.105 | 19.662 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 144.716 | 154.935 | 161.741 | 107.449 | 109.025 |
| 價值變動淨收益/利潤總額(%) | 1.814 | -5.709 | -3.723 | 8.085 | -0.057 |
| 營業外收支淨額/利潤總額(%) | -2.230 | 0.645 | -0.106 | 0.995 | -0.111 | 償債能力分析 |
| 流動比率 (X) | 2.466 | 2.519 | 1.880 | 2.217 | 4.944 |
| 速動比率 (X) | 1.560 | 1.597 | 0.896 | 1.109 | 3.849 |
| 資產負債率 (%) | 47.959 | 47.243 | 39.739 | 35.183 | 22.986 |
| 帶息債務/全部投入資本 (%) | 35.168 | 33.212 | 24.232 | 15.367 | 0.695 |
| 股東權益/帶息債務 (%) | 163.046 | 177.147 | 282.011 | 492.789 | 12,717.344 |
| 股東權益/負債合計 (%) | 107.591 | 110.658 | 150.611 | 183.280 | 332.471 |
| 利息保障倍數 (X) | 9.313 | 7.906 | 5.025 | -342.766 | 34.569 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.075 | 77.061 | 75.320 | 63.743 | 41.668 |
| 存貨周轉天數 (天) | 346.355 | 351.690 | 359.057 | 344.748 | 235.069 |
| 備註： | 即時報價更新時間為 30/05/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
